Alzheimer'S Disease Clinical Trials in Tampa, FL

Alzheimer'S Disease Clinical Trials in Tampa, FL

View the best 10 alzheimer's disease medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Alzheimer'S Disease clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for alzheimer's disease in Tampa, Florida

Image of California Neuroscience Research ( Site 0118) in Sherman Oaks, United States.

MK-1167

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial aims to investigate whether combining MK-1167 with acetylcholinesterase inhibitor therapy can help improve symptoms of Alzheimer's disease dementia, such as memory and mental activity. The study will
Image of Weill Cornell Medicine in New York, United States.

ExAblate Model 4000 Type 2.0 System

Ultrasound Therapy

Recruiting1 award5 criteria
This trial is testing a device that uses ultrasound waves to temporarily open the brain's protective barrier in patients with Alzheimer's Disease. The goal is to see if this can help medications reach the brain better. Focused ultrasound with microbubbles has been studied recently and shows promise for opening the brain's protective barrier in Alzheimer's disease treatment.
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.
Image of MD First Research - Chandler in Chandler, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing different doses of donanemab, a drug aimed at helping people with early Alzheimer's disease. Donanemab has shown rapid reduction of brain amyloid in early Alzheimer's disease. The study will look at how often and how severely participants experience a side effect involving brain swelling. Researchers also want to find out which patient characteristics might predict this side effect.
Image of Kingfisher Cooperative in Spokane, United States.

AR1001

Recruiting1 awardPhase 3
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.
Image of University of South Florida in Tampa, United States.

Computerized Cognitive Stimulation +1 More

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial will test if a cognitive training technique can help delay the onset of mild cognitive impairment or dementia.
Image of Sanders-Brown Center on Aging in Lexington, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial will test whether a new drug can help treat early Alzheimer's.
Image of Barrow Neurological Institute in Phoenix, United States.

Sensory Stimulation System (GS120)

Behavioural Intervention

Recruiting1 award
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this
Image of Conquest Clinical Research, LLC in Winter Park, United States.

Mevidalen

Recruiting0 awardsPhase 2
This trial aims to test the safety and effectiveness of a new drug called mevidalen in treating mild to moderate Alzheimer's Disease. Participants will be monitored for changes in memory, daily activities, sleep,
Image of North County Neurology Associates in Carlsbad, United States.

Placebo +2 More

Recruiting1 awardPhase 3
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.